In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis
The EMBO Journal · 2023
DOI: 10.15252/embj.2022110844 ↗Kurz gefasst
Fachartikel in der Zeitschrift The EMBO Journal, 2023. Verfasst von Gabriel Matos-Rodrigues und 19 weiteren Autor:innen. Beteiligte Einrichtung: Université de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Equipe Labellisée Ligue Contre le Cancer, Paris, France. Hauptthemen laut MEDLINE: Neoplasms, Rad51 Recombinase. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Institut National Du Cancer, ITMO Cancer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université de Paris, INSERM U1016, UMR 8104 CNRS, Institut Cochin, Equipe Labellisée Ligue Contre le Cancer, Paris, France.
- Université de Paris and Université Paris-Saclay, Laboratory of Development of the Gonads, IRCM/IBFJ CEA, UMR Genetic Stability Stem Cells and Radiation, Fontenay aux Roses, France.
- Université de Paris and Université Paris-Saclay, Inserm, IRCM/IBFJ CEA, UMR Genetic Stability Stem Cells and Radiation, Fontenay aux Roses, France.
- Genome Maintenance and Molecular Microscopy UMR8126 CNRS, Université Paris-Sud, Université Paris-Saclay, Gustave Roussy, Villejuif Cedex, France.
- Cell Death and Aging Team, INSERM U1030, Laboratory of Molecular Radiotherapy, University Paris-Sud and Gustave Roussy, Villejuif, France.
- CNRS UMR8200 Sorbonne Universités, UPMC University, Paris, France.
ORCID-Profile: Elodie Dardillac, Lucien Frappart, Patricia Kannouche, Pauline Dupaigne, Jean-Luc Perfettini, Emmanuelle Martini, Bernard S Lopez
Förderung
- NCI NIH HHS
- Institut National Du Cancer
- ITMO Cancer
- Ligue Contre le Cancer
Zitieren
APA
Matos-Rodrigues, G., Barroca, V., Muhammad, A. A., Dardillac, E., Allouch, A., Koundrioukoff, S., Lewandowski, D., Despras, E., Guirouilh-Barbat, J., Frappart, L., Kannouche, P., Dupaigne, P., Le Cam, E., Perfettini, J. L., Romeo, P. H., Debatisse, M., Jasin, M., Livera, G., Martini, E., & Lopez, B. S. (2023). In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis. The EMBO Journal. https://doi.org/10.15252/embj.2022110844
Vancouver
Matos-Rodrigues G, Barroca V, Muhammad AA, Dardillac E, Allouch A, Koundrioukoff S, et al. In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis. The EMBO Journal. 2023. doi:10.15252/embj.2022110844
BibTeX
@article{MatosRodrigues2023,
author = {Matos-Rodrigues, Gabriel and Barroca, Vilma and Muhammad, Ali-Akbar and Dardillac, Elodie and Allouch, Awatef and Koundrioukoff, Stephane and Lewandowski, Daniel and Despras, Emmanuelle and Guirouilh-Barbat, Josée and Frappart, Lucien and Kannouche, Patricia and Dupaigne, Pauline and Le Cam, Eric and Perfettini, Jean-Luc and Romeo, Paul-Henri and Debatisse, Michelle and Jasin, Maria and Livera, Gabriel and Martini, Emmanuelle and Lopez, Bernard S},
title = {In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis},
journal = {The EMBO Journal},
year = {2023},
doi = {10.15252/embj.2022110844}
}
EUVIMED